Hydroxychloroquine, azithromycin and ivermectin: treatments not recommended for Covid-19

被引：0
|
作者：
Buxeraud, Jacques
机构：
来源：
ACTUALITES PHARMACEUTIQUES | 2023年 / 62卷 / 627期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [21] Electrocardiograms of a COVID-19 patient treated with the combination of hydroxychloroquine and azithromycin
    Benouna, Mohamed Elghali
    Ech-Chenbouli, Amine
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2020, 35
  • [22] Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
    Xu, Jiuyang
    Cao, Bin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (01)
  • [23] Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
    Lamback, Elisa Baranski
    de Oliveira, Monica Amorim
    Haddad, Andrea Ferreira
    Marcondes Vieira, Andre Filipe
    Ferreira Neto, Armando Leao
    Maia, Taciana da Silva
    Chrisman, Juliana de Rezende
    de Mello Spineti, Pedro Pimenta
    de Mattos, Marco Antonio
    Costa, Eduardo
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2021, 25 (02):
  • [24] HYDROXYCHLOROQUINE AND AZITHROMYCIN COMBINATION COULD BE LETHAL TO COVID-19 PATIENTS
    Mohammad, Firdous Sayeed
    Karmakar, Varnita
    Irfan, Zainab
    [J]. FARMACIA, 2020, 68 (03) : 384 - 389
  • [25] Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19
    Seyhan, Avni Uygar
    Doganay, Fatih
    Yilmaz, Erdal
    Topal, Nurdan Papila
    Ak, Rohat
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (10): : S153 - S157
  • [26] COVID-19 AND QTC: IS HYDROXYCHLOROQUINE WORTH THE RISK? A REVIEW OF QT PROLONGATION IN HOSPITALISED COVID-19 PATIENTS TREATED WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN
    Pollock, A.
    Kumar, R.
    Devitt, P.
    Kent, B.
    Daly, C.
    [J]. HEART, 2020, 106 : A1 - A1
  • [27] Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients
    Cadegiani, F. A.
    Goren, A.
    Wambier, C. G.
    McCoy, J.
    [J]. NEW MICROBES AND NEW INFECTIONS, 2021, 43
  • [28] Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
    Megarbane, Bruno
    Scherrmann, Jean-Michel
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (07): : 808 - 814
  • [29] Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
    Gautret, Philippe
    Lagier, Jean-Christophe
    Honore, Stephane
    Van Thuan Hoang
    Raoult, Didier
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (01)
  • [30] Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
    Li, Chunfeng
    Cheng, Genhong
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
12345